Cherry Hill

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Depression2 trials

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Recruiting2 trials

Lead sponsor

• Axsome Therapeutics, Inc.2 trials

Running trials

• Recruiting

  Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  NCT07484217· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

• Recruiting

  A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  NCT06223880· Phase 4· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression2 recruiting